{
    "organizations": [],
    "uuid": "a18afe91c8895d1ee49b22ae1decc0621fb68c2d",
    "author": "cnbc.com",
    "url": "http://www.cnbc.com/2018/01/03/globe-newswire-inspiremd-schedules-conference-call-to-discuss-recent-developments-preliminary-sales-results-and-proposals-for-upcoming.html",
    "ord_in_thread": 0,
    "title": "InspireMD Schedules Conference Call to Discuss Recent Developments, Preliminary Sales Results and Proposals for Upcoming Shareholder Meeting",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "TEL AVIV, ISRAEL, Jan. 03, 2018 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE AMER: NSPR), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that it will host a conference call on Wednesday, January 10th at 10:00 a.m. Eastern Time to discuss recent developments, preliminary unaudited fourth quarter 2017 sales results, and proposals under consideration for the upcoming shareholder meeting. A link to the Company’s definitive proxy statement is available at: https://www.sec.gov/Archives/edgar/data/1433607/000149315217015034/def14a.htm .\nThe conference call will be available via telephone by dialing toll free 877-407-0782 for U.S. callers or +1 201-689-8567 for international callers, or on the Company’s Investor Relations section of the website: http://www.inspiremd.com/en/investors/investor-relations/ .\nA webcast will also be archived on the Company’s website and a telephone replay of the call will be available approximately one hour following the call, through midnight January 24, 2018, and can be accessed by dialing 877-481-4010 for U.S. callers or +1 919-882-2331 for international callers and entering conference ID: 23561.\nAbout InspireMD, Inc.\nInspireMD seeks to utilize its proprietary MicroNet™ technology to make its products the industry standard for embolic protection and to provide a superior solution to the key clinical issues of current stenting in patients with a high risk of distal embolization, no reflow and major adverse cardiac events.\nInspireMD intends to pursue applications of this MicroNet technology in coronary, carotid (CGuard™), neurovascular, and peripheral artery procedures. InspireMD's common stock is Quote: d on the NYSE American under the ticker symbol NSPR and certain warrants are Quote: d on the NYSE American under the ticker symbol NSPR.WS.\nInvestor Contacts: InspireMD, Inc. Craig Shore Chief Financial Officer Phone: 1-888-776-6804 Email: craigs@inspiremd.com Crescendo Communications, LLC David Waldman Phone: (212) 671-1021 Email: NSPR@crescendo-ir.com\nSource:InspireMD, Inc.",
    "published": "2018-01-04T00:05:00.000+02:00",
    "crawled": "2018-01-04T00:34:03.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "tel",
        "aviv",
        "israel",
        "globe",
        "newswire",
        "inspiremd",
        "nyse",
        "amer",
        "nspr",
        "leader",
        "embolic",
        "prevention",
        "system",
        "eps",
        "thrombus",
        "management",
        "technology",
        "neurovascular",
        "device",
        "today",
        "announced",
        "host",
        "conference",
        "call",
        "wednesday",
        "january",
        "10th",
        "eastern",
        "time",
        "discus",
        "recent",
        "development",
        "preliminary",
        "unaudited",
        "fourth",
        "quarter",
        "sale",
        "result",
        "proposal",
        "consideration",
        "upcoming",
        "shareholder",
        "meeting",
        "link",
        "company",
        "definitive",
        "proxy",
        "statement",
        "available",
        "http",
        "conference",
        "call",
        "available",
        "via",
        "telephone",
        "dialing",
        "toll",
        "free",
        "caller",
        "international",
        "caller",
        "company",
        "investor",
        "relation",
        "section",
        "website",
        "http",
        "webcast",
        "also",
        "archived",
        "company",
        "website",
        "telephone",
        "replay",
        "call",
        "available",
        "approximately",
        "one",
        "hour",
        "following",
        "call",
        "midnight",
        "january",
        "accessed",
        "dialing",
        "caller",
        "international",
        "caller",
        "entering",
        "conference",
        "id",
        "inspiremd",
        "inspiremd",
        "seek",
        "utilize",
        "proprietary",
        "technology",
        "make",
        "product",
        "industry",
        "standard",
        "embolic",
        "protection",
        "provide",
        "superior",
        "solution",
        "key",
        "clinical",
        "issue",
        "current",
        "stenting",
        "patient",
        "high",
        "risk",
        "distal",
        "embolization",
        "reflow",
        "major",
        "adverse",
        "cardiac",
        "event",
        "inspiremd",
        "intends",
        "pursue",
        "application",
        "micronet",
        "technology",
        "coronary",
        "carotid",
        "neurovascular",
        "peripheral",
        "artery",
        "procedure",
        "inspiremd",
        "common",
        "stock",
        "quote",
        "nyse",
        "american",
        "ticker",
        "symbol",
        "nspr",
        "certain",
        "warrant",
        "quote",
        "nyse",
        "american",
        "ticker",
        "symbol",
        "investor",
        "contact",
        "inspiremd",
        "craig",
        "shore",
        "chief",
        "financial",
        "officer",
        "phone",
        "email",
        "craigs",
        "crescendo",
        "communication",
        "llc",
        "david",
        "waldman",
        "phone",
        "email",
        "nspr",
        "source",
        "inspiremd",
        "inc"
    ]
}